This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Disposable Insulin-Delivery Device Market

Demand for disposable insulin delivery devices is primarily driven by factors such as increased technology breakthroughs and an increase in obesity prevalence

Disposable Insulin-Delivery Device Market by Product, Disease Indication, Distribution Channel & Region - Forecast 2022 - 2032

Disposable Insulin-Delivery Device Market Snapshot (2022-2032)

[296 Pages Report] The global disposable insulin-delivery device market is anticipated to be valued at US$ 14,585.6 Million in 2022, forecast to grow at a CAGR of 7.7% to be valued at US$ 32,887.5 Million from 2022 to 2032. Growth is attributed to surge in the diabetes-related health expenditure in emerging economies.

Diabetes is one of the most chronic and life-threatening diseases that affects a large population of the world. Diabetes, also known as diabetes mellitus, is a metabolic disorder wherein the pancreas is not able to produce insulin or the body is not able to utilize insulin to metabolize glucose.

Data Points

Key Statistics

Growth Rate (2016-2021)

6.8% CAGR

Projected Growth Rate (2022-2032)

7.7% CAGR

Expected Market Value (2022)

US$ 14,585.6 Million

Anticipated Forecast Value (2032)

US$ 32,887.5 Million

There are mainly three distinct types of diabetes, Type I Diabetes, Type II Diabetes and gestational diabetes. The growing prevalence of diabetes is the key factor promoting market growth. The increased prevalence of diabetes has also contributed to the surging mortality rate, which in turn is expected to fuel the growth of the disposable insulin delivery device market.

On the contrary, stringent government rules and regulations governing the product approval process and the high cost of insulin analogs in diabetes care management are expected to hamper the growth of the disposable insulin-delivery device market over the analysis period.

Customize this Report

Let us know your requirement to get
100% FREE customization

Which are Some Prominent Drivers Spearheading Disposable Insulin-Delivery Device Market Growth?

Technological Advancement in Healthcare to Propel the Growth of the Market

Factors such as favorable reimbursement scenarios and strong government support in selected countries, technological advancements in insulin delivery devices, a growing diabetic population, and rising awareness about insulin delivery devices are expected to propel the growth of the Disposable Insulin-Delivery Market over the analysis period.

Moreover, other factors that are anticipated to augment the market growth include a surge in diabetes-related health expenditure in emerging economies, and the increase in the conferences, meetings, and congresses for rising awareness about insulin delivery devices, which in turn will assist in the expansion of the market.

Additionally, a rise in research and development activities extends profitable opportunities to the market players during the forecast period. Also, technological advancements in insulin delivery devices will assist in the expansion of the market. Risk factors, such as obesity and being overweight are highly linked to the incidence of diabetes, which is rising by epidemic proportions, thus rendering a high prevalence of diabetes, which in turn is expected to boost the market growth.

Latest trends in the market, such as the launch of high-end insulin pumps, syringes, and pens, are driving demand for disposable insulin delivery devices. To achieve a significant market share, leading disposable insulin delivery device companies are focused on technological advances and the creation of innovative products.

What are the Challenges Faced by the Disposable Insulin-Delivery Device Industry?

High out-of-pocket expenditure in emerging economies and stringent government regulations are expected to hinder the growth of the Disposable Insulin-Delivery Device Market during the forecast period.

In addition, issues associated with the reuse of pen needles and infusion sets and poor reimbursement structure in developing countries are some other factors that are expected to hamper the market growth.

Furthermore, stringent government rules and regulations governing the product approval process and the high cost of insulin analogs in diabetes care management could impede market growth in the near future.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Why is North America Emerging as an Opportunistic Disposable Insulin-Delivery Device Market?

Rising Prevalence of Diabetes Boosting Sales of Disposable Insulin Delivery Device in North America

In terms of regional platforms, North America holds the major market share in the disposable insulin-delivery device market. The region is expected to capture a 33.4% share in 2022. Growth in the country is underpinned by the rising prevalence of diabetes, favorable government initiatives, a booming disposable insulin delivery device market, and the heavy presence of leading disposable insulin delivery device manufacturers.

North America is the biggest market for the Disposable Insulin-Delivery Device market to ensure compliance with business processes and legal issues. The region is expected to show significant growth in the Disposable Insulin-Delivery Device market, attributed to the prevalence of diabetes and favorable reimbursement scenario within the region. According to the Centers for Disease Control and Prevention (CDC), there are over 37.3 million people with diabetes in the United States.

How is Europe Contributing to the Growth of the Disposable Insulin-Delivery Device Market?

Increasing Medical Tourism in Europe Expected to Favor Demand for Dialysis Devices and Concentrates

According to Future Market Insights, Europe is expected to provide immense growth opportunities for disposable insulin-delivery devices and is expected to reach the highest share of 29.4% in 2022. Europe is expected to witness significant market growth, attributed to the rise in patient awareness of the disease in the region.

Europe is the second major contributor to the global disposable insulin delivery device market in terms of value due to the increasing prevalence of diabetes and the increase in healthcare expenditure for diabetes treatment in the various parts of Europe.

For instance, about 32.3 million adults were diagnosed with diabetes in the European Union in 2019, up from an estimated 16.8 million adults in 2000. An additional 24.2 million people in Europe were estimated to have diabetes but be undiagnosed in 2019 Thus, the large patient base suffering from diabetes and its growing prevalence is expected to boost the growth in this region.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Will the Asia Pacific emerge as an Attractive Disposable Insulin Delivery Device Market?

Growing health consciousness as well as an increase in the diabetic population, are the key reasons driving growth

As per the analysis, the market in the Asia Pacific is projected to dominate the market during the forecast period. Disposable insulin delivery devices are widely used in Asian countries such as China and India. Factors such as increased diabetes awareness and an altering healthcare landscape are to blame for the increased sales of disposable insulin delivery devices in Asia Pacific countries.

Developing countries, like China and India, are expected to witness the highest growth during the study period due to the presence of a large population base suffering from diabetes and its rising awareness amongst individuals. Furthermore, increased healthcare spending has resulted in increased adoption of technologically advanced products in countries such as China and India, which is projected to enhance market growth.

Role of Start-ups in Disposable Insulin-Delivery Device Market

There are many prominent market players in the disposable insulin-delivery device market, who are working hand-in-hand to provide the best-in-class Disposable Insulin-Delivery Devices for enhancing the global insulin device arena. However, there are many global start-ups in the Disposable Insulin-Delivery Device Market, who are stepping forward in matching the requirements of the Disposable Insulin-Delivery Device domain.

Some of the start-ups operating in the disposable insulin-delivery device market are Tandem Diabetes, Insulet, Valeritas, Kaleido, Companion Medical, CeQur, Ypsomed, Aerami, EoFlow, Sigrid Therapeutics

  • In May 2022 - EOFlow Co., Ltd. announces the official launching of iOS Version of ‘Narsha,’ a smartphone application for wearable insulin pump in Korea.

Market Competition

Some of the key participants present in the global disposable insulin-delivery device market include Animas Corporation, F. Hoffmann-La Roche AG, Insulet Corporation, Medtronic Plc., Valeritas, Inc., Tandem Diabetes Care, Inc., Johnson & Johnson, Beta Bionics, Inc. Abbott Laboratories, Becton Dickinson & Co., and EyeSense GmbH among others.

Attributed to the presence of such high number of participants, the market is highly competitive. While global players such as Animas Corporation, F. Hoffmann-La Roche AG, and Insulet Corporation, Medtronic Plc., account for a considerable market size, several regional level players are also operating across key growth regions, particularly in North America.

Recent Developments form the market are listed below

  • In March 2022, Novo Nordisk announced that two smart connected insulin pens, NovoPen 6 and NovoPen Echo Plus, are available on prescription for people living with diabetes treated with Novo Nordisk insulin in the United Kingdom.
  • In January 2022, Boston-based Insulet Corp. announced that the FDA (Food and Drug Administration) had cleared the new Omnipod 5 system, marking the company’s entry into the automated insulin delivery (AID) universe.
  • In February 2022: Abbott, announced collaborations with key health-tech partners BeatO, Sugar.fit, PharmEasy, GOQii, 1MG, Zyla Health, Healthifyme and Fitterfly to usher a new era of holistic diabetes management care. Through these collaborations, Abbott offer glucose monitoring solutions to 8 million people living with diabetes, of which approximately 6.5mn users can access through PharmEasy and 1MG. The company is focused on maintaining effective glucose level along with remote consultations, diabetes-specific coaching, and dietary plan.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 7.7% from 2022 to 2032

Market Value in 2022

US$ 14,585.6 Million

Market Value in 2032

US$ 32,887.5 Million

Base Year for Estimation

2021

Historical Data

2016-2021

Forecast Period

2022-2032

Quantitative Units

Revenue in USD Million and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Company Ranking, Competitive Landscape,

Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Products
  • Disease Indication
  • Distribution Channel
  • Region

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • India
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • GCC
  • South Africa
  • Israel

Key Companies Profiled

  • Animas Corporation
  • F. Hoffmann-La Roche AG
  • Insulet Corporation
  • Medtronic Plc.
  • Valeritas, Inc.,
  • Tandem Diabetes Care, Inc.
  • Johnson & Johnson
  • Beta Bionics Inc.
  • Abbott Laboratories
  • Becton Dickinson & Co.
  • EyeSense GmbH

Customization

Available Upon Request

Key Segments Profiled in the Disposable Insulin-Delivery Device Market

Disposable Insulin-Delivery Device Market by Product Type:

  • Disposable Insulin-Delivery Pumps
  • Disposable Insulin-Delivery Patches
  • Disposable Insulin-Delivery Pens
  • Disposable Insulin-Delivery Syringes

Disposable Insulin-Delivery Device Market by Disease Indication:

  • Disposable Insulin-Delivery Devices for Type I Diabetes
  • Disposable Insulin-Delivery Devices for Type II Diabetes

Disposable Insulin-Delivery Device Market by Distribution Channel:

  • Disposable Insulin-Delivery Devices Sales via Hospital Pharmacies
  • Disposable Insulin-Delivery Devices Sales via Retail Pharmacies
  • Disposable Insulin-Delivery Devices Sales via Online Sales
  • Disposable Insulin-Delivery Devices Sales via Diabetes Clinics

Disposable Insulin-Delivery Device Market by Region:

  • North America Disposable Insulin-Delivery Device Market
  • Latin America Disposable Insulin-Delivery Device Market
  • Europe Disposable Insulin-Delivery Device Market
  • Asia Pacific Disposable Insulin-Delivery Device Market
  • Middle East & Africa Disposable Insulin-Delivery Device Market

Frequently Asked Questions

FMI projects the global disposable insulin-delivery device market to expand at a 7.7% value CAGR by 2032

North America is expected to be the most opportunistic Disposable Insulin-Delivery Device market, expanding at a 33.4% CAGR

Animas Corporation, F. Hoffmann-La Roche AG, and Insulet Corporation, Medtronic Plc., are some prominent Disposable Insulin-Delivery Device manufacturers

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2016-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2016-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2016-2021 and Forecast 2022-2032, By Products

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Products, 2016-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Products, 2022-2032

        5.3.1. Insulin Pumps

        5.3.2. Insulin Patches

        5.3.3. Insulin Pens

        5.3.4. Insulin Syringes

    5.4. Y-o-Y Growth Trend Analysis By Products, 2016-2021

    5.5. Absolute $ Opportunity Analysis By Products, 2022-2032

6. Global Market Analysis 2016-2021 and Forecast 2022-2032, By Disease Indication

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By Disease Indication, 2016-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Disease Indication, 2022-2032

        6.3.1. Type I Diabetes

        6.3.2. Type II Diabetes

    6.4. Y-o-Y Growth Trend Analysis By Disease Indication, 2016-2021

    6.5. Absolute $ Opportunity Analysis By Disease Indication, 2022-2032

7. Global Market Analysis 2016-2021 and Forecast 2022-2032, By Distribution Channel

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Mn) Analysis By Distribution Channel, 2016-2021

    7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2022-2032

        7.3.1. Hospital Pharmacies

        7.3.2. Retail Pharmacies

        7.3.3. Online Sales

        7.3.4. Diabetes Clinics

    7.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2016-2021

    7.5. Absolute $ Opportunity Analysis By Distribution Channel, 2022-2032

8. Global Market Analysis 2016-2021 and Forecast 2022-2032, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2016-2021

    8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. Asia Pacific

        8.3.5. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. U.S.

            9.2.1.2. Canada

        9.2.2. By Products

        9.2.3. By Disease Indication

        9.2.4. By Distribution Channel

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Products

        9.3.3. By Disease Indication

        9.3.4. By Distribution Channel

    9.4. Key Takeaways

10. Latin America Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Products

        10.2.3. By Disease Indication

        10.2.4. By Distribution Channel

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Products

        10.3.3. By Disease Indication

        10.3.4. By Distribution Channel

    10.4. Key Takeaways

11. Europe Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. U.K.

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Europe

        11.2.2. By Products

        11.2.3. By Disease Indication

        11.2.4. By Distribution Channel

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Products

        11.3.3. By Disease Indication

        11.3.4. By Distribution Channel

    11.4. Key Takeaways

12. Asia Pacific Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

            12.2.1.4. India

            12.2.1.5. Malaysia

            12.2.1.6. Singapore

            12.2.1.7. Australia

            12.2.1.8. New Zealand

            12.2.1.9. Rest of APAC

        12.2.2. By Products

        12.2.3. By Disease Indication

        12.2.4. By Distribution Channel

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Products

        12.3.3. By Disease Indication

        12.3.4. By Distribution Channel

    12.4. Key Takeaways

13. MEA Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. GCC Countries

            13.2.1.2. South Africa

            13.2.1.3. Israel

            13.2.1.4. Rest of MEA

        13.2.2. By Products

        13.2.3. By Disease Indication

        13.2.4. By Distribution Channel

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Products

        13.3.3. By Disease Indication

        13.3.4. By Distribution Channel

    13.4. Key Takeaways

14. Key Countries Market Analysis

    14.1. U.S.

        14.1.1. Pricing Analysis

        14.1.2. Market Share Analysis, 2021

            14.1.2.1. By Products

            14.1.2.2. By Disease Indication

            14.1.2.3. By Distribution Channel

    14.2. Canada

        14.2.1. Pricing Analysis

        14.2.2. Market Share Analysis, 2021

            14.2.2.1. By Products

            14.2.2.2. By Disease Indication

            14.2.2.3. By Distribution Channel

    14.3. Brazil

        14.3.1. Pricing Analysis

        14.3.2. Market Share Analysis, 2021

            14.3.2.1. By Products

            14.3.2.2. By Disease Indication

            14.3.2.3. By Distribution Channel

    14.4. Mexico

        14.4.1. Pricing Analysis

        14.4.2. Market Share Analysis, 2021

            14.4.2.1. By Products

            14.4.2.2. By Disease Indication

            14.4.2.3. By Distribution Channel

    14.5. Germany

        14.5.1. Pricing Analysis

        14.5.2. Market Share Analysis, 2021

            14.5.2.1. By Products

            14.5.2.2. By Disease Indication

            14.5.2.3. By Distribution Channel

    14.6. U.K.

        14.6.1. Pricing Analysis

        14.6.2. Market Share Analysis, 2021

            14.6.2.1. By Products

            14.6.2.2. By Disease Indication

            14.6.2.3. By Distribution Channel

    14.7. France

        14.7.1. Pricing Analysis

        14.7.2. Market Share Analysis, 2021

            14.7.2.1. By Products

            14.7.2.2. By Disease Indication

            14.7.2.3. By Distribution Channel

    14.8. Spain

        14.8.1. Pricing Analysis

        14.8.2. Market Share Analysis, 2021

            14.8.2.1. By Products

            14.8.2.2. By Disease Indication

            14.8.2.3. By Distribution Channel

    14.9. Italy

        14.9.1. Pricing Analysis

        14.9.2. Market Share Analysis, 2021

            14.9.2.1. By Products

            14.9.2.2. By Disease Indication

            14.9.2.3. By Distribution Channel

    14.10. China

        14.10.1. Pricing Analysis

        14.10.2. Market Share Analysis, 2021

            14.10.2.1. By Products

            14.10.2.2. By Disease Indication

            14.10.2.3. By Distribution Channel

    14.11. Japan

        14.11.1. Pricing Analysis

        14.11.2. Market Share Analysis, 2021

            14.11.2.1. By Products

            14.11.2.2. By Disease Indication

            14.11.2.3. By Distribution Channel

    14.12. South Korea

        14.12.1. Pricing Analysis

        14.12.2. Market Share Analysis, 2021

            14.12.2.1. By Products

            14.12.2.2. By Disease Indication

            14.12.2.3. By Distribution Channel

    14.13. Malaysia

        14.13.1. Pricing Analysis

        14.13.2. Market Share Analysis, 2021

            14.13.2.1. By Products

            14.13.2.2. By Disease Indication

            14.13.2.3. By Distribution Channel

    14.14. Singapore

        14.14.1. Pricing Analysis

        14.14.2. Market Share Analysis, 2021

            14.14.2.1. By Products

            14.14.2.2. By Disease Indication

            14.14.2.3. By Distribution Channel

    14.15. Australia

        14.15.1. Pricing Analysis

        14.15.2. Market Share Analysis, 2021

            14.15.2.1. By Products

            14.15.2.2. By Disease Indication

            14.15.2.3. By Distribution Channel

    14.16. New Zealand

        14.16.1. Pricing Analysis

        14.16.2. Market Share Analysis, 2021

            14.16.2.1. By Products

            14.16.2.2. By Disease Indication

            14.16.2.3. By Distribution Channel

    14.17. GCC Countries

        14.17.1. Pricing Analysis

        14.17.2. Market Share Analysis, 2021

            14.17.2.1. By Products

            14.17.2.2. By Disease Indication

            14.17.2.3. By Distribution Channel

    14.18. South Africa

        14.18.1. Pricing Analysis

        14.18.2. Market Share Analysis, 2021

            14.18.2.1. By Products

            14.18.2.2. By Disease Indication

            14.18.2.3. By Distribution Channel

    14.19. Israel

        14.19.1. Pricing Analysis

        14.19.2. Market Share Analysis, 2021

            14.19.2.1. By Products

            14.19.2.2. By Disease Indication

            14.19.2.3. By Distribution Channel

15. Market Structure Analysis

    15.1. Competition Dashboard

    15.2. Competition Benchmarking

    15.3. Market Share Analysis of Top Players

        15.3.1. By Regional

        15.3.2. By Products

        15.3.3. By Disease Indication

        15.3.4. By Distribution Channel

16. Competition Analysis

    16.1. Competition Deep Dive

        16.1.1. Animas Corporation

            16.1.1.1. Overview

            16.1.1.2. Product Portfolio

            16.1.1.3. Profitability by Market Segments

            16.1.1.4. Sales Footprint

            16.1.1.5. Strategy Overview

                16.1.1.5.1. Marketing Strategy

        16.1.2. F. Hoffmann-La Roche AG

            16.1.2.1. Overview

            16.1.2.2. Product Portfolio

            16.1.2.3. Profitability by Market Segments

            16.1.2.4. Sales Footprint

            16.1.2.5. Strategy Overview

                16.1.2.5.1. Marketing Strategy

        16.1.3. Insulet Corporation

            16.1.3.1. Overview

            16.1.3.2. Product Portfolio

            16.1.3.3. Profitability by Market Segments

            16.1.3.4. Sales Footprint

            16.1.3.5. Strategy Overview

                16.1.3.5.1. Marketing Strategy

        16.1.4. Medtronic Plc.

            16.1.4.1. Overview

            16.1.4.2. Product Portfolio

            16.1.4.3. Profitability by Market Segments

            16.1.4.4. Sales Footprint

            16.1.4.5. Strategy Overview

                16.1.4.5.1. Marketing Strategy

        16.1.5. Valeritas, Inc.

            16.1.5.1. Overview

            16.1.5.2. Product Portfolio

            16.1.5.3. Profitability by Market Segments

            16.1.5.4. Sales Footprint

            16.1.5.5. Strategy Overview

                16.1.5.5.1. Marketing Strategy

        16.1.6. Tandem Diabetes Care, Inc.

            16.1.6.1. Overview

            16.1.6.2. Product Portfolio

            16.1.6.3. Profitability by Market Segments

            16.1.6.4. Sales Footprint

            16.1.6.5. Strategy Overview

                16.1.6.5.1. Marketing Strategy

        16.1.7. Johnson & Johnson

            16.1.7.1. Overview

            16.1.7.2. Product Portfolio

            16.1.7.3. Profitability by Market Segments

            16.1.7.4. Sales Footprint

            16.1.7.5. Strategy Overview

                16.1.7.5.1. Marketing Strategy

        16.1.8. Beta Bionics, Inc.

            16.1.8.1. Overview

            16.1.8.2. Product Portfolio

            16.1.8.3. Profitability by Market Segments

            16.1.8.4. Sales Footprint

            16.1.8.5. Strategy Overview

                16.1.8.5.1. Marketing Strategy

        16.1.9. Abbott Laboratories

            16.1.9.1. Overview

            16.1.9.2. Product Portfolio

            16.1.9.3. Profitability by Market Segments

            16.1.9.4. Sales Footprint

            16.1.9.5. Strategy Overview

                16.1.9.5.1. Marketing Strategy

        16.1.10. Becton Dickinson & Co.

            16.1.10.1. Overview

            16.1.10.2. Product Portfolio

            16.1.10.3. Profitability by Market Segments

            16.1.10.4. Sales Footprint

            16.1.10.5. Strategy Overview

                16.1.10.5.1. Marketing Strategy

        16.1.11. EyeSense GmbH

            16.1.11.1. Overview

            16.1.11.2. Product Portfolio

            16.1.11.3. Profitability by Market Segments

            16.1.11.4. Sales Footprint

            16.1.11.5. Strategy Overview

                16.1.11.5.1. Marketing Strategy

17. Assumptions & Acronyms Used

18. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Market Value (US$ Mn) Forecast by Region, 2016-2032

Table 2: Global Market Value (US$ Mn) Forecast by Products, 2016-2032

Table 3: Global Market Value (US$ Mn) Forecast by Disease Indication, 2016-2032

Table 4: Global Market Value (US$ Mn) Forecast by Distribution Channel, 2016-2032

Table 5: North America Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 6: North America Market Value (US$ Mn) Forecast by Products, 2016-2032

Table 7: North America Market Value (US$ Mn) Forecast by Disease Indication, 2016-2032

Table 8: North America Market Value (US$ Mn) Forecast by Distribution Channel, 2016-2032

Table 9: Latin America Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 10: Latin America Market Value (US$ Mn) Forecast by Products, 2016-2032

Table 11: Latin America Market Value (US$ Mn) Forecast by Disease Indication, 2016-2032

Table 12: Latin America Market Value (US$ Mn) Forecast by Distribution Channel, 2016-2032

Table 13: Europe Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 14: Europe Market Value (US$ Mn) Forecast by Products, 2016-2032

Table 15: Europe Market Value (US$ Mn) Forecast by Disease Indication, 2016-2032

Table 16: Europe Market Value (US$ Mn) Forecast by Distribution Channel, 2016-2032

Table 17: Asia Pacific Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 18: Asia Pacific Market Value (US$ Mn) Forecast by Products, 2016-2032

Table 19: Asia Pacific Market Value (US$ Mn) Forecast by Disease Indication, 2016-2032

Table 20: Asia Pacific Market Value (US$ Mn) Forecast by Distribution Channel, 2016-2032

Table 21: MEA Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 22: MEA Market Value (US$ Mn) Forecast by Products, 2016-2032

Table 23: MEA Market Value (US$ Mn) Forecast by Disease Indication, 2016-2032

Table 24: MEA Market Value (US$ Mn) Forecast by Distribution Channel, 2016-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Market Value (US$ Mn) by Products, 2022-2032

Figure 2: Global Market Value (US$ Mn) by Disease Indication, 2022-2032

Figure 3: Global Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 4: Global Market Value (US$ Mn) by Region, 2022-2032

Figure 5: Global Market Value (US$ Mn) Analysis by Region, 2016-2032

Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 8: Global Market Value (US$ Mn) Analysis by Products, 2016-2032

Figure 9: Global Market Value Share (%) and BPS Analysis by Products, 2022-2032

Figure 10: Global Market Y-o-Y Growth (%) Projections by Products, 2022-2032

Figure 11: Global Market Value (US$ Mn) Analysis by Disease Indication, 2016-2032

Figure 12: Global Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032

Figure 13: Global Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032

Figure 14: Global Market Value (US$ Mn) Analysis by Distribution Channel, 2016-2032

Figure 15: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 16: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 17: Global Market Attractiveness by Products, 2022-2032

Figure 18: Global Market Attractiveness by Disease Indication, 2022-2032

Figure 19: Global Market Attractiveness by Distribution Channel, 2022-2032

Figure 20: Global Market Attractiveness by Region, 2022-2032

Figure 21: North America Market Value (US$ Mn) by Products, 2022-2032

Figure 22: North America Market Value (US$ Mn) by Disease Indication, 2022-2032

Figure 23: North America Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 24: North America Market Value (US$ Mn) by Country, 2022-2032

Figure 25: North America Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 28: North America Market Value (US$ Mn) Analysis by Products, 2016-2032

Figure 29: North America Market Value Share (%) and BPS Analysis by Products, 2022-2032

Figure 30: North America Market Y-o-Y Growth (%) Projections by Products, 2022-2032

Figure 31: North America Market Value (US$ Mn) Analysis by Disease Indication, 2016-2032

Figure 32: North America Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032

Figure 33: North America Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032

Figure 34: North America Market Value (US$ Mn) Analysis by Distribution Channel, 2016-2032

Figure 35: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 36: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 37: North America Market Attractiveness by Products, 2022-2032

Figure 38: North America Market Attractiveness by Disease Indication, 2022-2032

Figure 39: North America Market Attractiveness by Distribution Channel, 2022-2032

Figure 40: North America Market Attractiveness by Country, 2022-2032

Figure 41: Latin America Market Value (US$ Mn) by Products, 2022-2032

Figure 42: Latin America Market Value (US$ Mn) by Disease Indication, 2022-2032

Figure 43: Latin America Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 44: Latin America Market Value (US$ Mn) by Country, 2022-2032

Figure 45: Latin America Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 48: Latin America Market Value (US$ Mn) Analysis by Products, 2016-2032

Figure 49: Latin America Market Value Share (%) and BPS Analysis by Products, 2022-2032

Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Products, 2022-2032

Figure 51: Latin America Market Value (US$ Mn) Analysis by Disease Indication, 2016-2032

Figure 52: Latin America Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032

Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032

Figure 54: Latin America Market Value (US$ Mn) Analysis by Distribution Channel, 2016-2032

Figure 55: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 57: Latin America Market Attractiveness by Products, 2022-2032

Figure 58: Latin America Market Attractiveness by Disease Indication, 2022-2032

Figure 59: Latin America Market Attractiveness by Distribution Channel, 2022-2032

Figure 60: Latin America Market Attractiveness by Country, 2022-2032

Figure 61: Europe Market Value (US$ Mn) by Products, 2022-2032

Figure 62: Europe Market Value (US$ Mn) by Disease Indication, 2022-2032

Figure 63: Europe Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 64: Europe Market Value (US$ Mn) by Country, 2022-2032

Figure 65: Europe Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 68: Europe Market Value (US$ Mn) Analysis by Products, 2016-2032

Figure 69: Europe Market Value Share (%) and BPS Analysis by Products, 2022-2032

Figure 70: Europe Market Y-o-Y Growth (%) Projections by Products, 2022-2032

Figure 71: Europe Market Value (US$ Mn) Analysis by Disease Indication, 2016-2032

Figure 72: Europe Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032

Figure 73: Europe Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032

Figure 74: Europe Market Value (US$ Mn) Analysis by Distribution Channel, 2016-2032

Figure 75: Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 76: Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 77: Europe Market Attractiveness by Products, 2022-2032

Figure 78: Europe Market Attractiveness by Disease Indication, 2022-2032

Figure 79: Europe Market Attractiveness by Distribution Channel, 2022-2032

Figure 80: Europe Market Attractiveness by Country, 2022-2032

Figure 81: Asia Pacific Market Value (US$ Mn) by Products, 2022-2032

Figure 82: Asia Pacific Market Value (US$ Mn) by Disease Indication, 2022-2032

Figure 83: Asia Pacific Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 84: Asia Pacific Market Value (US$ Mn) by Country, 2022-2032

Figure 85: Asia Pacific Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 86: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 87: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 88: Asia Pacific Market Value (US$ Mn) Analysis by Products, 2016-2032

Figure 89: Asia Pacific Market Value Share (%) and BPS Analysis by Products, 2022-2032

Figure 90: Asia Pacific Market Y-o-Y Growth (%) Projections by Products, 2022-2032

Figure 91: Asia Pacific Market Value (US$ Mn) Analysis by Disease Indication, 2016-2032

Figure 92: Asia Pacific Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032

Figure 93: Asia Pacific Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032

Figure 94: Asia Pacific Market Value (US$ Mn) Analysis by Distribution Channel, 2016-2032

Figure 95: Asia Pacific Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 96: Asia Pacific Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 97: Asia Pacific Market Attractiveness by Products, 2022-2032

Figure 98: Asia Pacific Market Attractiveness by Disease Indication, 2022-2032

Figure 99: Asia Pacific Market Attractiveness by Distribution Channel, 2022-2032

Figure 100: Asia Pacific Market Attractiveness by Country, 2022-2032

Figure 101: MEA Market Value (US$ Mn) by Products, 2022-2032

Figure 102: MEA Market Value (US$ Mn) by Disease Indication, 2022-2032

Figure 103: MEA Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 104: MEA Market Value (US$ Mn) by Country, 2022-2032

Figure 105: MEA Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 106: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 107: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 108: MEA Market Value (US$ Mn) Analysis by Products, 2016-2032

Figure 109: MEA Market Value Share (%) and BPS Analysis by Products, 2022-2032

Figure 110: MEA Market Y-o-Y Growth (%) Projections by Products, 2022-2032

Figure 111: MEA Market Value (US$ Mn) Analysis by Disease Indication, 2016-2032

Figure 112: MEA Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032

Figure 113: MEA Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032

Figure 114: MEA Market Value (US$ Mn) Analysis by Distribution Channel, 2016-2032

Figure 115: MEA Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 116: MEA Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 117: MEA Market Attractiveness by Products, 2022-2032

Figure 118: MEA Market Attractiveness by Disease Indication, 2022-2032

Figure 119: MEA Market Attractiveness by Distribution Channel, 2022-2032

Figure 120: MEA Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Veterinary Insulin Drugs Market

Published : April 2020

Healthcare

Insulin Delivery Pens Market

Published : November 2017

Healthcare

Insulin Management System Market

Published : December 2016

Healthcare

Insulin Biosimilars Market

Published : September 2016

Google translate

Disposable Insulin-Delivery Device Market